A Single Arm Phase I/II Study of Tazemetostat with Rituximab and Abbreviated Bendamustine in the Frontline Treatment of High Tumor Burden Follicular Lymphoma

Status: Open to Accrual

Learn more

• https://clinicaltrials.gov/study/NCT05551936
• See study locations on Big Ten CRC website

Study Contact: studies@hoosiercancer.org; 317-921-2050